Overview
Registration
Agenda
View Archive

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity has been approved for 1.5 AMA PRA Category 1 Credits™.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing Provider #16669, for 1.5 Contact Hours.

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Sanofi Genzyme.

Cases and Conversations: The Importance of Newborn Screening for MPS 1 – How Can We Optimize Patient Outcomes From the Beginning?

Cases and Conversations: The Importance of Newborn Screening for MPS 1 – How Can We Optimize Patient Outcomes From the Beginning?


Thursday, April 15, 2021

Live, Interactive Webcast!

8:00 - 9:30 AM EST

Overview

Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive disorder characterized by deficiency of α-L-iduronidase (IDUA), which results in accumulation of the glycosaminoglycans (GAGs) dermatan and heparan sulfate in cells throughout the body. Clinical heterogeneity of MPS I is evident by the fact that symptoms can be nonspecific and may be associated with various rheumatological disorders. The irreversible nature of the symptoms and ailments caused by the accumulation and excess storage of GAG highlights the need for timely, accurate diagnosis and early treatment intervention.

Most physicians do not have knowledge or clinical experience managing this rare disease, and their lack of experience can create risks of poor outcomes for patients. In this program, a panel of experts will discuss the diagnosis and management of MPS 1, guided with case studies to highlight practical application. In-depth panel discussions will allow for the audience to submit their own questions via ARS for discussion by the experts.

Benefits of Attending

  • Identify the best methods for early diagnosis of patients with MPS 1
  • Learn when to start therapy for patients with MPS 1
  • Know how to prevent the complications associated with MPS 1
  • Understand the effectiveness of new therapies for patients with MPS 1

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Sanofi Genzyme.

Target Audience

This educational activity is directed toward health care professionals who regularly manage MPS I, including pediatricians, geneticists, and specialists in rare genetic disorders.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Describe the pathophysiology of MPS I
  • Select appropriate assessments to confirm an MPS I diagnosis based on screening results
  • Analyze current and emerging therapies in the treatment of patients with MPS I
  • Apply patient-centered approaches toward the management of patients with MPS I

Program Chair

Barbara K. Burton, MD
Barbara K. Burton, MD
Attending Physician, Division of Genetics, Birth Defects and Metabolism
Ann & Robert H. Lurie Children’s Hospital
Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, IL

Registration

2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701

Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
 
Registration Fee - Free


For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.



Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
 123456
78910111213
14151617181920
21222324252627
28293031
Filter By